Start Date
July 19, 2022
Primary Completion Date
October 31, 2022
Study Completion Date
October 31, 2022
Plerixafor 20 MG/ML [Mozobil]
Plerixafor (Mozobil®) continuous intravenous infusion for 7 days
Placebo
Placebo continuous intravenous infusion for 7 days
University First Multiprofile Hospital for Active Treatment Sofia St John the Baptist, Sofia
Military Medical Academy Multiprofile Hospital for Active Treatment Sofia, Sofia
University Hospital for Active Treatment and Emergency Medicine NI Pirogov EAD, Sofia
MHAT Sveta Anna Sofia AD, Sofia
University Multiprofile Hospital for Active Treatment Sveti Georgi EAD, Plovdiv
Multiprofile Hospital For Active Treatment Pazardzhik AD, Pazardzhik
University Multiprofile Hospital for Active Treatment Prof Dr Stoyan Kirkovich AD, Stara Zagora
Multiprofile Hospital for Active Treatment AD Haskovo, Haskovo
Multiprofile Hospital for Active Treatment Dr Ivan SeliminskiSliven AD, Sliven
Hôpital Saint André, Bordeaux
Hôpital Haut-Lévêque, Pessac
Hôpital Civil de Strasbourg, Strasbourg
Centre Hospitalier Départemental de Vendée - Les Oudairies, La Roche-sur-Yon
Centre Hospitalier d'Argenteuil, Argenteuil
Lead Sponsor
4Living Biotech
INDUSTRY